Chemed Corporation
CHE
$555.74
$8.961.64%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.23% | 7.38% | 7.60% | 5.19% | 7.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.23% | 7.38% | 7.60% | 5.19% | 7.18% |
| Cost of Revenue | 13.26% | 9.34% | 4.16% | 3.89% | 2.51% |
| Gross Profit | 2.88% | 3.87% | 14.76% | 7.73% | 15.47% |
| SG&A Expenses | 3.80% | 2.39% | 7.65% | 15.76% | 3.62% |
| Depreciation & Amortization | 1.88% | 2.07% | 3.73% | 6.82% | 6.37% |
| Other Operating Expenses | 86.05% | -53.64% | 305.56% | -94.71% | -489.43% |
| Total Operating Expenses | 11.31% | 7.61% | 4.84% | 6.07% | 2.30% |
| Operating Income | 0.59% | 6.11% | 26.79% | -0.67% | 33.68% |
| Income Before Tax | 3.92% | 8.32% | 33.38% | 18.72% | 40.28% |
| Income Tax Expenses | 16.70% | 37.94% | 35.21% | 14.22% | 25.97% |
| Earnings from Continuing Operations | 0.30% | 1.09% | 32.80% | 20.13% | 44.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.30% | 1.09% | 32.80% | 20.13% | 44.95% |
| EBIT | 0.59% | 6.11% | 26.79% | -0.67% | 33.68% |
| EBITDA | 0.93% | 5.50% | 22.66% | 0.60% | 32.48% |
| EPS Basic | 1.96% | 1.43% | 32.46% | 18.90% | 43.17% |
| Normalized Basic EPS | 4.00% | 8.68% | 33.04% | 17.50% | 35.21% |
| EPS Diluted | 2.13% | 1.42% | 32.48% | 18.44% | 43.19% |
| Normalized Diluted EPS | 4.20% | 8.55% | 33.11% | 16.95% | 34.94% |
| Average Basic Shares Outstanding | -1.63% | -0.33% | 0.26% | 1.04% | 1.25% |
| Average Diluted Shares Outstanding | -1.82% | -0.21% | 0.21% | 1.52% | 1.45% |
| Dividend Per Share | 25.00% | 25.00% | 5.26% | 5.26% | 5.26% |
| Payout Ratio | 0.23% | 0.23% | -0.20% | -0.11% | -0.26% |